CLSD - Clearside Biomedical GAAP EPS of -$0.08 beats by $0.01 revenue of $6.35M beats by $2.11M
2024-03-12 16:06:52 ET
More on Clearside Biomedical
- Clearside to sell 11.11M shares at $1.35 in registered direct offering
- Clearside Biomedical reports progress in ODYSSEY Phase 2b trial of CLS-AX
- Seeking Alpha’s Quant Rating on Clearside Biomedical
- Historical earnings data for Clearside Biomedical
- Financial information for Clearside Biomedical